News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
365,931 Results
Type
Article (14460)
Company Profile (114)
Press Release (351357)
Multimedia
Podcasts (38)
Webinars (7)
Section
Business (112642)
Career Advice (456)
Deals (18613)
Drug Delivery (29)
Drug Development (31181)
Employer Resources (50)
FDA (8796)
Job Trends (7676)
News (172765)
Policy (12358)
Tag
Academia (1323)
Accelerated approval (3)
Allergies (42)
Alliances (34838)
ALS (27)
Alzheimer's disease (519)
Antibody-drug conjugate (ADC) (81)
Approvals (8830)
Artificial intelligence (254)
Autoimmune disease (5)
Automation (13)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (7)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (31)
Brain cancer (13)
Breast cancer (124)
Cancer (1088)
Cardiovascular disease (68)
Career advice (408)
Career pathing (9)
CAR-T (110)
Cell therapy (282)
Cervical cancer (11)
Clinical research (24553)
Collaboration (633)
Compensation (118)
Complete response letters (3)
COVID-19 (1148)
CRISPR (41)
C-suite (153)
Cystic fibrosis (47)
Data (1057)
Decentralized trials (1)
Denatured (18)
Depression (17)
Diabetes (110)
Diagnostics (4928)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (26)
Earnings (38953)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51572)
Executive appointments (422)
FDA (9522)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (498)
Gene editing (94)
Generative AI (24)
Gene therapy (184)
GLP-1 (229)
Government (1235)
Grass and pollen (2)
Guidances (84)
Healthcare (9895)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Indications (13)
Infectious disease (1226)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (33)
Intellectual property (65)
Interviews (52)
IPO (8018)
IRA (8)
Job creations (1436)
Job search strategy (362)
Kidney cancer (4)
Labor market (10)
Layoffs (119)
Leadership (3)
Legal (2521)
Liver cancer (36)
Lung cancer (130)
Lymphoma (67)
Machine learning (7)
Management (17)
Manufacturing (198)
MASH (16)
Medical device (11508)
Medtech (11513)
Mergers & acquisitions (10964)
Metabolic disorders (226)
Multiple sclerosis (30)
NASH (3)
Neurodegenerative disease (32)
Neuropsychiatric disorders (4)
Neuroscience (723)
NextGen: Class of 2025 (3535)
Non-profit (1522)
Now hiring (9)
Obesity (95)
Opinion (77)
Ovarian cancer (41)
Pain (53)
Pancreatic cancer (42)
Parkinson's disease (68)
Partnered (12)
Patents (155)
Patient recruitment (59)
Peanut (26)
People (32816)
Pharmaceutical (16)
Phase I (9055)
Phase II (11079)
Phase III (7182)
Pipeline (652)
Policy (32)
Postmarket research (501)
Preclinical (4111)
Press Release (66)
Prostate cancer (46)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (138)
Real estate (3365)
Recruiting (20)
Regulatory (9422)
Reports (18)
Research institute (1270)
Resumes & cover letters (68)
Rett syndrome (4)
RNA editing (2)
RSV (23)
Schizophrenia (13)
Series A (90)
Series B (55)
Service/supplier (7)
Sickle cell disease (19)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2508)
State (2)
Stomach cancer (2)
Supply chain (27)
Tariffs (6)
The Weekly (19)
Vaccines (327)
Venture capitalists (19)
Weight loss (35)
Women's health (18)
Worklife (2)
Date
Last 7 days (464)
Last 30 days (1526)
Last 365 days (16893)
2025 (6059)
2024 (18710)
2023 (22098)
2022 (30814)
2021 (32512)
2020 (30537)
2019 (25793)
2018 (19458)
2017 (18872)
2016 (17761)
2015 (20561)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Alabama (42)
Alaska (6)
Arizona (125)
Arkansas (10)
Asia (24116)
Australia (4195)
California (3097)
Canada (1080)
China (256)
Colorado (174)
Connecticut (133)
Delaware (49)
Europe (49303)
Florida (510)
Georgia (141)
Idaho (33)
Illinois (294)
India (13)
Indiana (169)
Iowa (5)
Japan (125)
Kansas (85)
Kentucky (7)
Louisiana (7)
Maine (20)
Maryland (478)
Massachusetts (2148)
Michigan (189)
Minnesota (261)
Mississippi (2)
Missouri (62)
Montana (24)
Nebraska (15)
Nevada (25)
New Hampshire (67)
New Jersey (962)
New Mexico (16)
New York (904)
North Carolina (550)
North Dakota (8)
Northern California (1174)
Ohio (106)
Oklahoma (11)
Oregon (20)
Pennsylvania (629)
Puerto Rico (11)
Rhode Island (25)
South America (507)
South Carolina (23)
South Dakota (1)
Southern California (1272)
Tennessee (64)
Texas (500)
United States (12200)
Utah (114)
Virginia (60)
Washington D.C. (13)
Washington State (346)
West Virginia (3)
Wisconsin (41)
365,931 Results for "nexalin technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock
May 6, 2025
·
4 min read
Press Releases
Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia
April 24, 2025
·
4 min read
Press Releases
Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders
April 14, 2025
·
5 min read
Press Releases
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
April 3, 2025
·
4 min read
Press Releases
Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback
May 2, 2025
·
3 min read
Press Releases
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
February 26, 2025
·
4 min read
Press Releases
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
March 3, 2025
·
4 min read
Lone Star Bio
Nexalin Technology Announces Pricing of $5.2 Million Public Offering
Nexalin Technology, Inc. announced the pricing of a public offering of 3,000,000 shares of common stock at public offering price of $1.75.
June 27, 2024
·
3 min read
Lone Star Bio
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced today that it will be participating in the Spring MicroCap Rodeo Conference, that will be held on Thursday, June 6, 2024 in New York City.
June 4, 2024
·
3 min read
Press Releases
Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment
February 18, 2025
·
5 min read
1 of 36,594
Next
